Novartis Deals Add New Antibiotic and Discovery Programme
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 10 (Table of Contents)
Published: 24 Oct-2009
DOI: 10.3833/pdr.v2009.i10.1260 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Novartis bought worldwide rights for a potential first-in-class experimental antibiotic from Paratek Pharmaceuticals to treat highly resistant bacteria...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018